← Leaderboards
Weng-Lang Yang
Therasource, Llc
$7,053,625
Attributed
$7,053,625
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2010–18$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$7,053,625 · 8
By mechanism
R44$4,970,954 · 3
R43$2,082,671 · 5
Top collaborators
No co-investigators on record.
Most similar at Therasource, Llc
Same institution · by research overlap
- Max Brenner$5,242,481
- Rongqian Wu$5,339,526
- Wayne Chaung$4,402,397
- Xiaoling Qiang$2,651,330
- Asha Jacob$409,316
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsClinical TrialsRattusCytokineFutureMonitorSmall Business Innovation Research GrantDoseDrug KineticsPharmaceutical PreparationsInjuryPublic Health RelevanceSurvival RateBloodTissuesEffective TherapyAttenuatedInflammatoryPreclinical StudyCreatinineCessation Of LifeKidneyInterleukin-6Medical
Grant awards (16)
Human Ghrelin as an Effective Mitigator of Acute Radiation Injury$982,276
R44 · FY2018 · AI · contact PI
Preclinical Testing of Human Ghrelin and Growth Hormone for Sepsis in the Elderly$486,925
R44 · FY2018 · AG · contact PI
Human Ghrelin as an Effective Mitigator of Acute Radiation Injury$991,403
R44 · FY2017 · AI · contact PI
Preclinical Testing of Human Ghrelin and Growth Hormone for Sepsis in the Elderly$540,425
R44 · FY2017 · AG · contact PI
A Novel Recombinant Protein as an Effective Therapy for Acute Kidney Injury$112,808
R43 · FY2017 · DK · contact PI
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock$112,474
R43 · FY2017 · HL · contact PI
Human Ghrelin as an Effective Mitigator of Acute Radiation Injury$982,469
R44 · FY2016 · AI · contact PI
Preclinical Testing of Human Ghrelin and Growth Hormone for Sepsis in the Elderly$540,425
R44 · FY2016 · AG · contact PI
rhMFG-E8 as an Effective Adjuvant Therapy for Hemorrhagic Shock$224,951
R43 · FY2016 · HL · contact PI
A Novel Recombinant Protein as an Effective Therapy for Acute Kidney Injury$222,510
R43 · FY2016 · DK · contact PI
A Novel Recombinant Protein for Mitigating Total Body Radiation Injury$294,693
R43 · FY2015 · AI · contact PI
A Novel Recombinant Protein for Mitigating Total Body Radiation Injury$294,693
R43 · FY2014 · AI · contact PI
PRECLINICAL TESTING OF HUMAN GHRELIN AND GROWTH HORMONE FOR SEPSIS IN THE ELDLY$224,890
R43 · FY2014 · AG · contact PI
Human Ghrelin As An Effective Mitigator of Acute Radiation Injury$297,826
R43 · FY2012 · AI · contact PI
Human Ghrelin As An Effective Mitigator of Acute Radiation Injury$297,826
R43 · FY2011 · AI · contact PI
Treatment of Surgical Sepsis with AM/AMBP-1$447,031
R44 · FY2010 · GM · contact PI